Plain-English translation of NCT06445686 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a wearable wristband called Bora Band® can help catch early signs of serious flare-ups in people with idiopathic pulmonary fibrosis (a progressive lung condition that causes scarring). You would wear the device at home for a year while your regular medical team continues your normal care. The researchers want to see if the vital sign data collected by the device can predict when a flare-up is about to happen, before you even feel symptoms or need to see your doctor.
People with idiopathic pulmonary fibrosis can have sudden, serious flare-ups that are hard to predict and can be life-threatening. This trial exists to see if continuous monitoring of vital signs at home could catch warning signs early enough to alert doctors before a flare-up becomes severe, potentially helping prevent hospitalizations.
You would visit your pulmonologist for an initial appointment where you'll do a walking test and receive an oxygen prescription if needed. A home healthcare team would then visit to install the wearable wristband and a small data box in your home — these automatically track and upload your vital signs. Over 12 months, you'll have routine follow-up visits with your pulmonologist at 6 months and 12 months, including quality-of-life questionnaires. If you experience a flare-up during the study, the monitoring period extends an additional 3 months to collect extra data.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Sponsor
Biosency
Collaborators
Rennes University Hospital, Air de Bretagne
Enrollment target
~30 participants
Started
June 2024
Primary completion
February 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alexis TOULLEC
CHRU PONTCHAILLOU Rennes